相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of GLP-1 Agonist Therapy in Autosomal Dominant WFS1-Related Disorder: A Case Report
Kevin J. Scully et al.
HORMONE RESEARCH IN PAEDIATRICS (2021)
Glucagon like peptide-1 receptor agonists as neuroprotective agents for ischemic stroke: a systematic scoping review
Mark P. Maskery et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)
Liraglutide, 7,8-DHF and their co-treatment prevents loss of vision and cognitive decline in a Wolfram syndrome rat model
Kadri Seppa et al.
SCIENTIFIC REPORTS (2021)
Mild Phenotype of Wolfram Syndrome Associated With a Common Pathogenic Variant Is Predicted by a Structural Model of Wolframin
Adi Wilf-Yarkoni et al.
NEUROLOGY-GENETICS (2021)
Tolerance develops toward GLP-1 receptor agonists' glucose-lowering effect in mice
Tuuli Sedman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Longitudinal Assessment of Neuroradiologic Features in Wolfram Syndrome
A. Samara et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2020)
GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus
Lalita Dahiya et al.
CURRENT DIABETES REVIEWS (2020)
Optical coherence tomography and magnetic resonance imaging visual pathway evaluation in Wolfram syndrome
Agnieszka Zmyslowska et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2019)
The Discovery and Development of Liraglutide and Semaglutide
Lotte Bjerre Knudsen et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
The rat animal model for noise-induced hearing loss
Celia D. Escabi et al.
JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA (2019)
GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome
Kadri Seppa et al.
SCIENTIFIC REPORTS (2019)
Longitudinal hearing loss in Wolfram syndrome
Roanne Karzon et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Wolfram syndrome: MAMs' connection?
Benjamin Delprat et al.
CELL DEATH & DISEASE (2018)
Clinical Characteristics of Wolfram Syndrome in Chinese Population and a Novel Frameshift Mutation in WFS1
Lian Duan et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome
Manabu Kondo et al.
DIABETOLOGIA (2018)
Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome
Maarja Toots et al.
SCIENTIFIC REPORTS (2018)
Natural history and clinical characteristics of 50 patients with Wolfram syndrome
Gema Esteban Bueno et al.
ENDOCRINE (2018)
Wfs1-deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration
Mario Plaas et al.
SCIENTIFIC REPORTS (2017)
Wolfram Syndrome: Diagnosis, Management, and Treatment
Fumihiko Urano
CURRENT DIABETES REPORTS (2016)
A freely available semi-automated method for quantifying retinal ganglion cells in entire retinal flatmounts
E. Geeraerts et al.
EXPERIMENTAL EYE RESEARCH (2016)
Expression pattern of wolframin, the WFS1 (Wolfram syndrome-1 gene) product, in common marmoset (Callithrix jacchus) cochlea
Noriomi Suzuki et al.
NEUROREPORT (2016)
Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations
Gerd Luippold et al.
PLOS ONE (2016)
Role of Mitochondrial Dynamics in Neuronal Development: Mechanism for Wolfram Syndrome
Michal Cagalinec et al.
PLOS BIOLOGY (2016)
Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1
Tuuli Sedman et al.
JOURNAL OF DIABETES RESEARCH (2016)
Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin
Yoshiaki Katsuda et al.
EXPERIMENTAL ANIMALS (2015)
Ophthalmologic correlates of disease severity in children and adolescents with Wolfram syndrome
James Hoekel et al.
JOURNAL OF AAPOS (2014)
Impairment of Visual Function and Retinal ER Stress Activation in Wfs 1-Deficient Mice
Delphine Bonnet Wersinger et al.
PLOS ONE (2014)
Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype
Miguel Lopez de Heredia et al.
GENETICS IN MEDICINE (2013)
Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 (WFS1) protein, which regulates its expression and stability
Seley Gharanei et al.
HUMAN MOLECULAR GENETICS (2013)
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
Christian Hölscher
CNS DRUGS (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Neurologic Features and Genotype-Phenotype Correlation in Wolfram Syndrome
Annabelle Chaussenot et al.
ANNALS OF NEUROLOGY (2011)
Identification of two novel missense WFS1 mutations, H696Y and R703H, in patients with non-syndromic low-frequency sensorineural hearing loss
Yi Sun et al.
JOURNAL OF GENETICS AND GENOMICS (2011)
Wolfram syndrome: a clinicopathologic correlation
Justin B. Hilson et al.
ACTA NEUROPATHOLOGICA (2009)
Improvement of insulin response in the streptozotocin model of insulin-dependent diabetes mellitus. Insulin response with and without a long-acting insulin treatment
L. Nordquist et al.
ANIMAL (2009)
Brn3a as a Marker of Retinal Ganglion Cells: Qualitative and Quantitative Time Course Studies in Naive and Optic Nerve-Injured Retinas
Francisco M. Nadal-Nicolas et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid
Victor A. Gault et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Distribution of Wfs1 protein in the central nervous system of the mouse and its relation to clinical symptoms of the Wolfram syndrome
Hendrik Luuk et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy
TracyAnn Perry et al.
EXPERIMENTAL NEUROLOGY (2007)
GLP-1 receptor activation improves β cell function and survival following induction of endoplasmic reticulum stress
Bernardo Yusta et al.
CELL METABOLISM (2006)
Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene
H Eiberg et al.
JOURNAL OF MEDICAL GENETICS (2006)
WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic β-cells
SG Fonseca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The optomotor response:: A robust first-line visual screening method for mice
J Abdejalil et al.
VISION RESEARCH (2005)
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and α- and β-cell function and reduces endogenous glucose release in patients with type 2 diabetes
KB Degn et al.
DIABETES (2004)
The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes
H Harder et al.
DIABETES CARE (2004)
Mutations in the Wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss
MM Lesperance et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2003)
Otoacoustic emissions, their origin in cochlear function, and use
DT Kemp
BRITISH MEDICAL BULLETIN (2002)
分享论文
